APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Insulin Like Growth Factor 1 Receptor

Compare research editions
View pricing & licenses

Selected research

Industry Research

Insulin Like Growth Factor 1 Receptor Industry Research Report 2026

Report ID 174003610519 December 2025131 pages

Choose your research edition.

Industry ResearchInsulin Like Growth Factor 1 Receptor Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Insulin Like Growth Factor 1 Receptor Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Insulin Like Growth Factor 1 Receptor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Insulin Like Growth Factor 1 Receptor Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Insulin Like Growth Factor 1 Receptor Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Insulin Like Growth Factor 1 Receptor market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Insulin Like Growth Factor 1 Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Insulin Like Growth Factor 1 Receptor is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Insulin Like Growth Factor 1 Receptor is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Insulin Like Growth Factor 1 Receptor include Novartis AG, Merck & Co., Inc., Eli Lilly and Company, AstraZeneca Plc, ProteoThera, Inc., PharmAbcine, Inc., Merrimack Pharmaceuticals, Inc., Insmed Incorporated and Immunomedics, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Insulin Like Growth Factor 1 Receptor market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Insulin Like Growth Factor 1 Receptor Market by Company

Novartis AG

Merck & Co., Inc.

Eli Lilly and Company

AstraZeneca Plc

ProteoThera, Inc.

PharmAbcine, Inc.

Merrimack Pharmaceuticals, Inc.

Insmed Incorporated

Immunomedics, Inc.

Genmab A/S

F. Hoffmann-La Roche Ltd.

Bristol-Myers Squibb Company

Boehringer Ingelheim GmbH

Axelar AB

Astellas Pharma Inc.

Insulin Like Growth Factor 1 Receptor Segment by Type

CT-707

BI-893923

ATL-1101

1R-E1

Others

Insulin Like Growth Factor 1 Receptor Segment by Application

Hospital

Clinic

Others

Insulin Like Growth Factor 1 Receptor Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Insulin Like Growth Factor 1 Receptor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Insulin Like Growth Factor 1 Receptor and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Insulin Like Growth Factor 1 Receptor.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Insulin Like Growth Factor 1 Receptor manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Insulin Like Growth Factor 1 Receptor by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Insulin Like Growth Factor 1 Receptor in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Insulin Like Growth Factor 1 Receptor Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Insulin Like Growth Factor 1 Receptor Sales (W Units) of Manufacturers (2021-2026) Table 7. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Manufacturers (2021-2026) Table 8. Global Insulin Like Growth Factor 1 Receptor Revenue of Manufacturers (2021-2026) Table 9. Global Insulin Like Growth Factor 1 Receptor Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Insulin Like Growth Factor 1 Receptor Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Insulin Like Growth Factor 1 Receptor Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Insulin Like Growth Factor 1 Receptor, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Insulin Like Growth Factor 1 Receptor, Product Type & Application Table 14. Global Insulin Like Growth Factor 1 Receptor Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Insulin Like Growth Factor 1 Receptor by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Novartis AG Company Information Table 19. Novartis AG Business Overview Table 20. Novartis AG Insulin Like Growth Factor 1 Receptor Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Novartis AG Insulin Like Growth Factor 1 Receptor Product Portfolio Table 22. Novartis AG Recent Developments Table 23. Merck & Co., Inc. Company Information Table 24. Merck & Co., Inc. Business Overview Table 25. Merck & Co., Inc. Insulin Like Growth Factor 1 Receptor Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Merck & Co., Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio Table 27. Merck & Co., Inc. Recent Developments Table 28. Eli Lilly and Company Company Information Table 29. Eli Lilly and Company Business Overview Table 30. Eli Lilly and Company Insulin Like Growth Factor 1 Receptor Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Eli Lilly and Company Insulin Like Growth Factor 1 Receptor Product Portfolio Table 32. Eli Lilly and Company Recent Developments Table 33. AstraZeneca Plc Company Information Table 34. AstraZeneca Plc Business Overview Table 35. AstraZeneca Plc Insulin Like Growth Factor 1 Receptor Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. AstraZeneca Plc Insulin Like Growth Factor 1 Receptor Product Portfolio Table 37. AstraZeneca Plc Recent Developments Table 38. ProteoThera, Inc. Company Information Table 39. ProteoThera, Inc. Business Overview Table 40. ProteoThera, Inc. Insulin Like Growth Factor 1 Receptor Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. ProteoThera, Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio Table 42. ProteoThera, Inc. Recent Developments Table 43. PharmAbcine, Inc. Company Information Table 44. PharmAbcine, Inc. Business Overview Table 45. PharmAbcine, Inc. Insulin Like Growth Factor 1 Receptor Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. PharmAbcine, Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio Table 47. PharmAbcine, Inc. Recent Developments Table 48. Merrimack Pharmaceuticals, Inc. Company Information Table 49. Merrimack Pharmaceuticals, Inc. Business Overview Table 50. Merrimack Pharmaceuticals, Inc. Insulin Like Growth Factor 1 Receptor Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Merrimack Pharmaceuticals, Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio Table 52. Merrimack Pharmaceuticals, Inc. Recent Developments Table 53. Insmed Incorporated Company Information Table 54. Insmed Incorporated Business Overview Table 55. Insmed Incorporated Insulin Like Growth Factor 1 Receptor Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Insmed Incorporated Insulin Like Growth Factor 1 Receptor Product Portfolio Table 57. Insmed Incorporated Recent Developments Table 58. Immunomedics, Inc. Company Information Table 59. Immunomedics, Inc. Business Overview Table 60. Immunomedics, Inc. Insulin Like Growth Factor 1 Receptor Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Immunomedics, Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio Table 62. Immunomedics, Inc. Recent Developments Table 63. Genmab A/S Company Information Table 64. Genmab A/S Business Overview Table 65. Genmab A/S Insulin Like Growth Factor 1 Receptor Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Genmab A/S Insulin Like Growth Factor 1 Receptor Product Portfolio Table 67. Genmab A/S Recent Developments Table 68. F. Hoffmann-La Roche Ltd. Company Information Table 69. F. Hoffmann-La Roche Ltd. Business Overview Table 70. F. Hoffmann-La Roche Ltd. Insulin Like Growth Factor 1 Receptor Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. F. Hoffmann-La Roche Ltd. Insulin Like Growth Factor 1 Receptor Product Portfolio Table 72. F. Hoffmann-La Roche Ltd. Recent Developments Table 73. Bristol-Myers Squibb Company Company Information Table 74. Bristol-Myers Squibb Company Business Overview Table 75. Bristol-Myers Squibb Company Insulin Like Growth Factor 1 Receptor Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Bristol-Myers Squibb Company Insulin Like Growth Factor 1 Receptor Product Portfolio Table 77. Bristol-Myers Squibb Company Recent Developments Table 78. Boehringer Ingelheim GmbH Company Information Table 79. Boehringer Ingelheim GmbH Business Overview Table 80. Boehringer Ingelheim GmbH Insulin Like Growth Factor 1 Receptor Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Boehringer Ingelheim GmbH Insulin Like Growth Factor 1 Receptor Product Portfolio Table 82. Boehringer Ingelheim GmbH Recent Developments Table 83. Axelar AB Company Information Table 84. Axelar AB Business Overview Table 85. Axelar AB Insulin Like Growth Factor 1 Receptor Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Axelar AB Insulin Like Growth Factor 1 Receptor Product Portfolio Table 87. Axelar AB Recent Developments Table 88. Astellas Pharma Inc. Company Information Table 89. Astellas Pharma Inc. Business Overview Table 90. Astellas Pharma Inc. Insulin Like Growth Factor 1 Receptor Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Astellas Pharma Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio Table 92. Astellas Pharma Inc. Recent Developments Table 93. Global Insulin Like Growth Factor 1 Receptor Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 94. Global Insulin Like Growth Factor 1 Receptor Sales by Region (2021-2026) & (W Units) Table 95. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Region (2021-2026) Table 96. Global Insulin Like Growth Factor 1 Receptor Sales by Region (2027-2032) & (W Units) Table 97. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Region (2027-2032) Table 98. Global Insulin Like Growth Factor 1 Receptor Revenue by Region (2021-2026) & (US$ Million) Table 99. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Region (2021-2026) Table 100. Global Insulin Like Growth Factor 1 Receptor Revenue by Region (2027-2032) & (US$ Million) Table 101. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Region (2027-2032) Table 102. North America Insulin Like Growth Factor 1 Receptor Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. North America Insulin Like Growth Factor 1 Receptor Sales by Country (2021-2026) & (W Units) Table 104. North America Insulin Like Growth Factor 1 Receptor Sales by Country (2027-2032) & (W Units) Table 105. North America Insulin Like Growth Factor 1 Receptor Revenue by Country (2021-2026) & (US$ Million) Table 106. North America Insulin Like Growth Factor 1 Receptor Revenue by Country (2027-2032) & (US$ Million) Table 107. Europe Insulin Like Growth Factor 1 Receptor Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Europe Insulin Like Growth Factor 1 Receptor Sales by Country (2021-2026) & (W Units) Table 109. Europe Insulin Like Growth Factor 1 Receptor Sales by Country (2027-2032) & (W Units) Table 110. Europe Insulin Like Growth Factor 1 Receptor Revenue by Country (2021-2026) & (US$ Million) Table 111. Europe Insulin Like Growth Factor 1 Receptor Revenue by Country (2027-2032) & (US$ Million) Table 112. Asia Pacific Insulin Like Growth Factor 1 Receptor Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. Asia Pacific Insulin Like Growth Factor 1 Receptor Sales by Country (2021-2026) & (W Units) Table 114. Asia Pacific Insulin Like Growth Factor 1 Receptor Sales by Country (2027-2032) & (W Units) Table 115. Asia Pacific Insulin Like Growth Factor 1 Receptor Revenue by Country (2021-2026) & (US$ Million) Table 116. Asia Pacific Insulin Like Growth Factor 1 Receptor Revenue by Country (2027-2032) & (US$ Million) Table 117. South America Insulin Like Growth Factor 1 Receptor Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. South America Insulin Like Growth Factor 1 Receptor Sales by Country (2021-2026) & (W Units) Table 119. South America Insulin Like Growth Factor 1 Receptor Sales by Country (2027-2032) & (W Units) Table 120. South America Insulin Like Growth Factor 1 Receptor Revenue by Country (2021-2026) & (US$ Million) Table 121. South America Insulin Like Growth Factor 1 Receptor Revenue by Country (2027-2032) & (US$ Million) Table 122. Middle East and Africa Insulin Like Growth Factor 1 Receptor Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales by Country (2021-2026) & (W Units) Table 124. Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales by Country (2027-2032) & (W Units) Table 125. Middle East and Africa Insulin Like Growth Factor 1 Receptor Revenue by Country (2021-2026) & (US$ Million) Table 126. Middle East and Africa Insulin Like Growth Factor 1 Receptor Revenue by Country (2027-2032) & (US$ Million) Table 127. Global Insulin Like Growth Factor 1 Receptor Sales by Type (2021-2026) & (W Units) Table 128. Global Insulin Like Growth Factor 1 Receptor Sales by Type (2027-2032) & (W Units) Table 129. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Type (2021-2026) Table 130. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Type (2027-2032) Table 131. Global Insulin Like Growth Factor 1 Receptor Revenue by Type (2021-2026) & (US$ Million) Table 132. Global Insulin Like Growth Factor 1 Receptor Revenue by Type (2027-2032) & (US$ Million) Table 133. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Type (2021-2026) Table 134. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Type (2027-2032) Table 135. Global Insulin Like Growth Factor 1 Receptor Price by Type (2021-2026) & (US$/Unit) Table 136. Global Insulin Like Growth Factor 1 Receptor Price by Type (2027-2032) & (US$/Unit) Table 137. Global Insulin Like Growth Factor 1 Receptor Sales by Application (2021-2026) & (W Units) Table 138. Global Insulin Like Growth Factor 1 Receptor Sales by Application (2027-2032) & (W Units) Table 139. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Application (2021-2026) Table 140. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Application (2027-2032) Table 141. Global Insulin Like Growth Factor 1 Receptor Revenue by Application (2021-2026) & (US$ Million) Table 142. Global Insulin Like Growth Factor 1 Receptor Revenue by Application (2027-2032) & (US$ Million) Table 143. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Application (2021-2026) Table 144. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Application (2027-2032) Table 145. Global Insulin Like Growth Factor 1 Receptor Price by Application (2021-2026) & (US$/Unit) Table 146. Global Insulin Like Growth Factor 1 Receptor Price by Application (2027-2032) & (US$/Unit) Table 147. Key Raw Materials Table 148. Raw Materials Key Suppliers Table 149. Insulin Like Growth Factor 1 Receptor Distributors List Table 150. Insulin Like Growth Factor 1 Receptor Customers List Table 151. Insulin Like Growth Factor 1 Receptor Industry Trends Table 152. Insulin Like Growth Factor 1 Receptor Industry Drivers Table 153. Insulin Like Growth Factor 1 Receptor Industry Restraints Table 154. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Insulin Like Growth Factor 1 Receptor Product Image Figure 5. Global Insulin Like Growth Factor 1 Receptor Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Insulin Like Growth Factor 1 Receptor Market Size (2021-2032) & (US$ Million) Figure 7. Global Insulin Like Growth Factor 1 Receptor Sales (2021-2032) & (W Units) Figure 8. Global Insulin Like Growth Factor 1 Receptor Average Price (US$/Unit) & (2021-2032) Figure 9. CT-707 Product Image Figure 10. BI-893923 Product Image Figure 11. ATL-1101 Product Image Figure 12. 1R-E1 Product Image Figure 13. Others Product Image Figure 14. Hospital Product Image Figure 15. Clinic Product Image Figure 16. Others Product Image Figure 17. Global Insulin Like Growth Factor 1 Receptor Revenue Share by Manufacturers in 2025 Figure 18. Global Manufacturers of Insulin Like Growth Factor 1 Receptor, Manufacturing Sites & Headquarters Figure 19. Global Top 5 and 10 Insulin Like Growth Factor 1 Receptor Players Market Share by Revenue in 2025 Figure 20. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Insulin Like Growth Factor 1 Receptor Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 22. Global Insulin Like Growth Factor 1 Receptor Sales by Region in 2025 Figure 23. Global Insulin Like Growth Factor 1 Receptor Revenue by Region in 2025 Figure 24. North America Insulin Like Growth Factor 1 Receptor Market Size by Country in 2025 Figure 25. North America Insulin Like Growth Factor 1 Receptor Sales Market Share by Country (2021-2032) Figure 26. North America Insulin Like Growth Factor 1 Receptor Revenue Market Share by Country (2021-2032) Figure 27. United States Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Canada Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Europe Insulin Like Growth Factor 1 Receptor Market Size by Country in 2025 Figure 30. Europe Insulin Like Growth Factor 1 Receptor Sales Market Share by Country (2021-2032) Figure 31. Europe Insulin Like Growth Factor 1 Receptor Revenue Market Share by Country (2021-2032) Figure 32. Germany Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. France Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. U.K. Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Italy Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Nordic Countries Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Asia Pacific Insulin Like Growth Factor 1 Receptor Market Size by Country in 2025 Figure 39. Asia Pacific Insulin Like Growth Factor 1 Receptor Sales Market Share by Country (2021-2032) Figure 40. Asia Pacific Insulin Like Growth Factor 1 Receptor Revenue Market Share by Country (2021-2032) Figure 41. China Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Japan Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. South Korea Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. India Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Australia Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. China Taiwan Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Southeast Asia Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Southeast Asia Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. South America Insulin Like Growth Factor 1 Receptor Market Size by Country in 2025 Figure 50. South America Insulin Like Growth Factor 1 Receptor Sales Market Share by Country (2021-2032) Figure 51. South America Insulin Like Growth Factor 1 Receptor Revenue Market Share by Country (2021-2032) Figure 52. Mexico Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Brazil Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Argentina Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Middle East and Africa Insulin Like Growth Factor 1 Receptor Market Size by Country in 2025 Figure 56. Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales Market Share by Country (2021-2032) Figure 57. Middle East and Africa Insulin Like Growth Factor 1 Receptor Revenue Market Share by Country (2021-2032) Figure 58. Turkey Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. UAE Insulin Like Growth Factor 1 Receptor Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Type (2021-2032) Figure 62. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Type (2021-2032) Figure 63. Global Insulin Like Growth Factor 1 Receptor Price (US$/Unit) by Type (2021-2032) Figure 64. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Application (2021-2032) Figure 65. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Application (2021-2032) Figure 66. Global Insulin Like Growth Factor 1 Receptor Price (US$/Unit) by Application (2021-2032) Figure 67. Insulin Like Growth Factor 1 Receptor Value Chain Figure 68. Insulin Like Growth Factor 1 Receptor Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Insulin Like Growth Factor 1 Receptor Industry Opportunities and Challenges

Scope & coverage.

Types
  • CT-707
  • BI-893923
  • ATL-1101
  • 1R-E1
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Novartis AG
  • Merck & Co., Inc.
  • Eli Lilly and Company
  • AstraZeneca Plc
  • ProteoThera, Inc.
  • PharmAbcine, Inc.
  • Merrimack Pharmaceuticals, Inc.
  • Insmed Incorporated
  • Immunomedics, Inc.
  • Genmab A/S
  • F. Hoffmann-La Roche Ltd.
  • Bristol-Myers Squibb Company
  • Boehringer Ingelheim GmbH
  • Axelar AB
  • Astellas Pharma Inc.

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Insulin Like Growth Factor 1 Receptor Market Size (2021-2032)
  4. 2.2.2 Global Insulin Like Growth Factor 1 Receptor Sales (2021-2032)
  5. 2.2.3 Global Insulin Like Growth Factor 1 Receptor Market Average Price (2021-2032)
  6. 2.3 Insulin Like Growth Factor 1 Receptor by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 CT-707
  9. 2.3.3 BI-893923
  10. 2.3.4 ATL-1101
  11. 2.3.5 1R-E1
  12. 2.3.6 Others
  13. 2.4 Insulin Like Growth Factor 1 Receptor by Application
  14. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  15. 2.4.2 Hospital
  16. 2.4.3 Clinic
  17. 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Insulin Like Growth Factor 1 Receptor Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Insulin Like Growth Factor 1 Receptor Sales (W Units) of Manufacturers (2021-2026)
  3. 3.3 Global Insulin Like Growth Factor 1 Receptor Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Insulin Like Growth Factor 1 Receptor Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Insulin Like Growth Factor 1 Receptor Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Insulin Like Growth Factor 1 Receptor, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Insulin Like Growth Factor 1 Receptor, Product Type & Application
  8. 3.8 Global Manufacturers of Insulin Like Growth Factor 1 Receptor, Established Date
  9. 3.9 Global Insulin Like Growth Factor 1 Receptor Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Novartis AG
  2. 4.1.1 Novartis AG Company Information
  3. 4.1.2 Novartis AG Business Overview
  4. 4.1.3 Novartis AG Insulin Like Growth Factor 1 Receptor Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Novartis AG Insulin Like Growth Factor 1 Receptor Product Portfolio
  6. 4.1.5 Novartis AG Recent Developments
  7. 4.2 Merck & Co., Inc.
  8. 4.2.1 Merck & Co., Inc. Company Information
  9. 4.2.2 Merck & Co., Inc. Business Overview
  10. 4.2.3 Merck & Co., Inc. Insulin Like Growth Factor 1 Receptor Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Merck & Co., Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio
  12. 4.2.5 Merck & Co., Inc. Recent Developments
  13. 4.3 Eli Lilly and Company
  14. 4.3.1 Eli Lilly and Company Company Information
  15. 4.3.2 Eli Lilly and Company Business Overview
  16. 4.3.3 Eli Lilly and Company Insulin Like Growth Factor 1 Receptor Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Eli Lilly and Company Insulin Like Growth Factor 1 Receptor Product Portfolio
  18. 4.3.5 Eli Lilly and Company Recent Developments
  19. 4.4 AstraZeneca Plc
  20. 4.4.1 AstraZeneca Plc Company Information
  21. 4.4.2 AstraZeneca Plc Business Overview
  22. 4.4.3 AstraZeneca Plc Insulin Like Growth Factor 1 Receptor Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 AstraZeneca Plc Insulin Like Growth Factor 1 Receptor Product Portfolio
  24. 4.4.5 AstraZeneca Plc Recent Developments
  25. 4.5 ProteoThera, Inc.
  26. 4.5.1 ProteoThera, Inc. Company Information
  27. 4.5.2 ProteoThera, Inc. Business Overview
  28. 4.5.3 ProteoThera, Inc. Insulin Like Growth Factor 1 Receptor Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 ProteoThera, Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio
  30. 4.5.5 ProteoThera, Inc. Recent Developments
  31. 4.6 PharmAbcine, Inc.
  32. 4.6.1 PharmAbcine, Inc. Company Information
  33. 4.6.2 PharmAbcine, Inc. Business Overview
  34. 4.6.3 PharmAbcine, Inc. Insulin Like Growth Factor 1 Receptor Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 PharmAbcine, Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio
  36. 4.6.5 PharmAbcine, Inc. Recent Developments
  37. 4.7 Merrimack Pharmaceuticals, Inc.
  38. 4.7.1 Merrimack Pharmaceuticals, Inc. Company Information
  39. 4.7.2 Merrimack Pharmaceuticals, Inc. Business Overview
  40. 4.7.3 Merrimack Pharmaceuticals, Inc. Insulin Like Growth Factor 1 Receptor Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Merrimack Pharmaceuticals, Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio
  42. 4.7.5 Merrimack Pharmaceuticals, Inc. Recent Developments
  43. 4.8 Insmed Incorporated
  44. 4.8.1 Insmed Incorporated Company Information
  45. 4.8.2 Insmed Incorporated Business Overview
  46. 4.8.3 Insmed Incorporated Insulin Like Growth Factor 1 Receptor Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Insmed Incorporated Insulin Like Growth Factor 1 Receptor Product Portfolio
  48. 4.8.5 Insmed Incorporated Recent Developments
  49. 4.9 Immunomedics, Inc.
  50. 4.9.1 Immunomedics, Inc. Company Information
  51. 4.9.2 Immunomedics, Inc. Business Overview
  52. 4.9.3 Immunomedics, Inc. Insulin Like Growth Factor 1 Receptor Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Immunomedics, Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio
  54. 4.9.5 Immunomedics, Inc. Recent Developments
  55. 4.10 Genmab A/S
  56. 4.10.1 Genmab A/S Company Information
  57. 4.10.2 Genmab A/S Business Overview
  58. 4.10.3 Genmab A/S Insulin Like Growth Factor 1 Receptor Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Genmab A/S Insulin Like Growth Factor 1 Receptor Product Portfolio
  60. 4.10.5 Genmab A/S Recent Developments
  61. 4.11 F. Hoffmann-La Roche Ltd.
  62. 4.11.1 F. Hoffmann-La Roche Ltd. Company Information
  63. 4.11.2 F. Hoffmann-La Roche Ltd. Business Overview
  64. 4.11.3 F. Hoffmann-La Roche Ltd. Insulin Like Growth Factor 1 Receptor Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 F. Hoffmann-La Roche Ltd. Insulin Like Growth Factor 1 Receptor Product Portfolio
  66. 4.11.5 F. Hoffmann-La Roche Ltd. Recent Developments
  67. 4.12 Bristol-Myers Squibb Company
  68. 4.12.1 Bristol-Myers Squibb Company Company Information
  69. 4.12.2 Bristol-Myers Squibb Company Business Overview
  70. 4.12.3 Bristol-Myers Squibb Company Insulin Like Growth Factor 1 Receptor Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Bristol-Myers Squibb Company Insulin Like Growth Factor 1 Receptor Product Portfolio
  72. 4.12.5 Bristol-Myers Squibb Company Recent Developments
  73. 4.13 Boehringer Ingelheim GmbH
  74. 4.13.1 Boehringer Ingelheim GmbH Company Information
  75. 4.13.2 Boehringer Ingelheim GmbH Business Overview
  76. 4.13.3 Boehringer Ingelheim GmbH Insulin Like Growth Factor 1 Receptor Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Boehringer Ingelheim GmbH Insulin Like Growth Factor 1 Receptor Product Portfolio
  78. 4.13.5 Boehringer Ingelheim GmbH Recent Developments
  79. 4.14 Axelar AB
  80. 4.14.1 Axelar AB Company Information
  81. 4.14.2 Axelar AB Business Overview
  82. 4.14.3 Axelar AB Insulin Like Growth Factor 1 Receptor Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Axelar AB Insulin Like Growth Factor 1 Receptor Product Portfolio
  84. 4.14.5 Axelar AB Recent Developments
  85. 4.15 Astellas Pharma Inc.
  86. 4.15.1 Astellas Pharma Inc. Company Information
  87. 4.15.2 Astellas Pharma Inc. Business Overview
  88. 4.15.3 Astellas Pharma Inc. Insulin Like Growth Factor 1 Receptor Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Astellas Pharma Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio
  90. 4.15.5 Astellas Pharma Inc. Recent Developments
5 Global Insulin Like Growth Factor 1 Receptor Market Scenario by Region
  1. 5.1 Global Insulin Like Growth Factor 1 Receptor Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Insulin Like Growth Factor 1 Receptor Sales by Region: 2021-2032
  3. 5.2.1 Global Insulin Like Growth Factor 1 Receptor Sales by Region: 2021-2026
  4. 5.2.2 Global Insulin Like Growth Factor 1 Receptor Sales by Region: 2027-2032
  5. 5.3 Global Insulin Like Growth Factor 1 Receptor Revenue by Region: 2021-2032
  6. 5.3.1 Global Insulin Like Growth Factor 1 Receptor Revenue by Region: 2021-2026
  7. 5.3.2 Global Insulin Like Growth Factor 1 Receptor Revenue by Region: 2027-2032
  8. 5.4 North America Insulin Like Growth Factor 1 Receptor Market Facts & Figures by Country
  9. 5.4.1 North America Insulin Like Growth Factor 1 Receptor Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Insulin Like Growth Factor 1 Receptor Sales by Country (2021-2032)
  11. 5.4.3 North America Insulin Like Growth Factor 1 Receptor Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Insulin Like Growth Factor 1 Receptor Market Facts & Figures by Country
  15. 5.5.1 Europe Insulin Like Growth Factor 1 Receptor Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Insulin Like Growth Factor 1 Receptor Sales by Country (2021-2032)
  17. 5.5.3 Europe Insulin Like Growth Factor 1 Receptor Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.5.9 Nordic Countries
  24. 5.6 Asia Pacific Insulin Like Growth Factor 1 Receptor Market Facts & Figures by Country
  25. 5.6.1 Asia Pacific Insulin Like Growth Factor 1 Receptor Market Size by Country: 2021 VS 2025 VS 2032
  26. 5.6.2 Asia Pacific Insulin Like Growth Factor 1 Receptor Sales by Country (2021-2032)
  27. 5.6.3 Asia Pacific Insulin Like Growth Factor 1 Receptor Revenue by Country (2021-2032)
  28. 5.6.4 China
  29. 5.6.5 Japan
  30. 5.6.6 South Korea
  31. 5.6.7 India
  32. 5.6.8 Australia
  33. 5.6.9 China Taiwan
  34. 5.6.10 Southeast Asia
  35. 5.7 South America Insulin Like Growth Factor 1 Receptor Market Facts & Figures by Country
  36. 5.7.1 South America Insulin Like Growth Factor 1 Receptor Market Size by Country: 2021 VS 2025 VS 2032
  37. 5.7.2 South America Insulin Like Growth Factor 1 Receptor Sales by Country (2021-2032)
  38. 5.7.3 South America Insulin Like Growth Factor 1 Receptor Revenue by Country (2021-2032)
  39. 5.7.4 Mexico
  40. 5.7.5 Brazil
  41. 5.7.6 Argentina
  42. 5.8 Middle East and Africa Insulin Like Growth Factor 1 Receptor Market Facts & Figures by Country
  43. 5.8.1 Middle East and Africa Insulin Like Growth Factor 1 Receptor Market Size by Country: 2021 VS 2025 VS 2032
  44. 5.8.2 Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales by Country (2021-2032)
  45. 5.8.3 Middle East and Africa Insulin Like Growth Factor 1 Receptor Revenue by Country (2021-2032)
  46. 5.8.4 Turkey
  47. 5.8.5 Saudi Arabia
  48. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Insulin Like Growth Factor 1 Receptor Sales by Type (2021-2032)
  2. 6.1.1 Global Insulin Like Growth Factor 1 Receptor Sales by Type (2021-2032) & (W Units)
  3. 6.1.2 Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Type (2021-2032)
  4. 6.2 Global Insulin Like Growth Factor 1 Receptor Revenue by Type (2021-2032)
  5. 6.2.1 Global Insulin Like Growth Factor 1 Receptor Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Insulin Like Growth Factor 1 Receptor Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Insulin Like Growth Factor 1 Receptor Sales by Application (2021-2032)
  2. 7.1.1 Global Insulin Like Growth Factor 1 Receptor Sales by Application (2021-2032) & (W Units)
  3. 7.1.2 Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Application (2021-2032)
  4. 7.2 Global Insulin Like Growth Factor 1 Receptor Revenue by Application (2021-2032)
  5. 7.2.1 Global Insulin Like Growth Factor 1 Receptor Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Insulin Like Growth Factor 1 Receptor Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Insulin Like Growth Factor 1 Receptor Value Chain Analysis
  2. 8.1.1 Insulin Like Growth Factor 1 Receptor Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Insulin Like Growth Factor 1 Receptor Production Mode & Process
  5. 8.2 Insulin Like Growth Factor 1 Receptor Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Insulin Like Growth Factor 1 Receptor Distributors
  8. 8.2.3 Insulin Like Growth Factor 1 Receptor Customers
9 Global Insulin Like Growth Factor 1 Receptor Analyzing Market Dynamics
  1. 9.1 Insulin Like Growth Factor 1 Receptor Industry Trends
  2. 9.2 Insulin Like Growth Factor 1 Receptor Industry Drivers
  3. 9.3 Insulin Like Growth Factor 1 Receptor Industry Opportunities and Challenges
  4. 9.4 Insulin Like Growth Factor 1 Receptor Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.
      Talk to an analyst